New York City-based Paige, a provider of computational pathology that diagnoses and treats cancer, has secured Series B funding. No financial terms were disclosed. The investor was Goldman Sachs Merchant Banking Division. In addition to the funding, David Castelblanco, a managing director at Goldman Sachs, has been added to Paige’s board of directors.
Source: Press Release